PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

Alkermes is focused on developing innovative medicines that aim to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated global biopharmaceutical company, we apply our scientific expertise and proprietary technologies to develop products that are designed to make a meaningful difference.
AAH is a leading distributor of pharmaceutical and healthcare products serving pharmacies, hospitals and doctors nationwide. In the UK, All About Health (AAH Pharmaceuticals Ltd) is the largest community pharmacy network and pharmaceutical wholesaler and part of McKesson UK.
We are a clinical-stage company developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases.
Our mission is to earn the trust of every customer, every day, by developing, manufacturing and supplying premium quality, good value, over-the-counter (OTC) pharmaceutical products and nutritional supplements to the worldwide market through advanced technology, great teamwork, tireless dedication and execution of sound business practices.
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms.
Alliance Pharma plc (AIM: APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries.
Allphase Clinical Research Inc is a full-service, Contract Research Organization (CRO) providing high quality clinical development management and strategy services for companies with early-stage to post-market approval products. We founded Allphase in 2001 with a mandate to be a highly trusted development partner providing intelligent, comprehensive and cost-efficient options, and a reliable industry recognized company.
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across, and beyond, the drug development lifecycle to the pharmaceutical and biotech sectors globally.
Almatica is focused on the development, acquisition and commercialization of brand named pharmaceutical products. We have a current portfolio of US branded pharmaceutical products covering a wide range of therapeutic areas including: psychiatry, pain management, anti-infectives and cardiovascular related disorders.
Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying science to provide medical solutions to patients and future generations. Our efforts are focused on fighting skin health diseases and helping people feel better.
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options.
Establish Alpha Genesis, Inc. (AGI) as the world’s premier provider of the finest nonhuman primate products and services while maintaining our uncompromising principles as we grow. AGI has enjoyed tremendous success and growth throughout the years, and as we have grown, we have strengthened our dedication to providing only the best and most cost-effective research and development support to the scientific community.
Alpharmaxim have been providing high-quality healthcare communications since 2001. Our experienced and committed staff have the scientific knowledge and strategic understanding to provide you with the trusted support you need to fulfil your promises.
Altabrisa Group is a pharmaceutical and biotech life sciences consulting firm specializing in quality, regulatory, and data integrity consulting and remediation. We provide expert consulting services to clients in the USA, India, Europe, Asia.
Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. The company has commercial operations in 20 countries with 1,700 employees.
We are a mid-size CRO with a consultative approach, ready to provide foresight and recommendations to sponsors on issues that inevitably arise during complex clinical trials. We have a strong track record on advising sponsors through the product development process, working together to provide customized solutions for each unique clinical study.
A rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve patient health. Our lead commercial product, VASCEPA® (icosapent ethyl), creates a new paradigm in cardiovascular disease management and is positioned to address cardiovascular risk for millions of patients globally.
Amarna Therapeutics is a privately held Biotech company founded in 2008. Its head office is located in Leiden (The Netherlands), and its research facility in Seville (Spain).